Loading insider details...
Beta
Latest Form 4 (Aug 20, 2026): Sale of 2,000 ARWR shares, $173.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 2,000 | $173.9K |
| May 14, 2026 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 22,700 | n/a |
| Dec 23, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 3,090 | $206.1K |
| Dec 18, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 7,819 | n/a |
| May 15, 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 10,000 | n/a |
| Feb 28, 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Other (see footnotes) | 1 | $1.55 |
| Jan 28, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 959 | $20.1K |
| Dec 30, 2024 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 2,850 | $57.0K |
| Dec 20, 2024 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 16,733 | $384.7K |
| May 24, 2024 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 104,621 | n/a |